End-users are confirming that Anobex is “an equivalent, 'drop-in' replacement for Barex,” reports Dan Mullock, COO at MSM Poly. Samples of converted Anobex (acrylonitrile methyl acrylate copolymer latex) have already been sent to a number of pharmaceutical companies after MSM Poly provided Anobex to film processors and converters, the company reports in a news release.
Initial testing results to date from end-users show no issues with equivalence, Peter Schmitt, managing member and CSO for MSM Poly, tells PMP News.
“These first commercial scale orders demonstrate the stability of MSM Poly’s production processes and quality program to meet and exceed requirements of pharmaceutical end users,” adds Pat Mickle, CEO of MSM Poly.
Anobex film processor Plastiques Venthenat, which has processed Barex, has found that “the resin processed well and both in terms of initial testing of properties and performance shows equivalence with Barex,” states Michel Rauturier, managing director, in the news release.
An equivalency portfolio is available to help end-users in the regulatory approval process, reports Steve Warakomski, MSM Poly’s CTO.
MSM Poly is currently ramping up capacity so the firm can provide sufficient quantities for the market by the 2nd Quarter of 2018. Anobex resin is currently available as pellets for film and sheet extrusion and injection molding as well as powder for calendering, coating, and compounding.
For more details on MSM Poly, see our article here.
MinnPack 2017 (Nov. 8-9; Minneapolis) celebrates its 15th year to bring you the latest developments in all things packaging as part of a comprehensive advanced manufacturing event. Sign up today to attend!